Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
TIDES Europe 2024TIDES Europe 2024
Not Confirmed
Not Confirmed
12-14 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
TIDES Europe 2024TIDES Europe 2024
Industry Trade Show
Not Confirmed
12-14 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
17 Jan 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/01/17/2589914/33448/en/Idera-Pharmaceuticals-Announces-Name-Change-to-Aceragen-Inc-and-Provides-Near-Term-Strategic-Outlook.html
17 Jan 2023
// Paul Schloesser ENDPTS
https://endpts.com/aeterna-discontinues-vaccine-development-idera-rebrands-as-aceragen/
14 Nov 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/11/14/2555472/33448/en/Idera-Pharmaceuticals-Reports-Third-Quarter-2022-Financial-Results-and-Provides-Corporate-Update.html
30 Sep 2022
// James Waldron FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/good-idera-pharma-buys-rare-disease-focused-aceragen-all-stock-deal-keep-money-flowing
28 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/28/2524718/0/en/Idera-Pharmaceuticals-Acquires-Aceragen.html
19 May 2022
// TRIALSITENEWS
https://www.trialsitenews.com/a/idera-stops-enrollment-in-phase-2-melanoma-trial-following-positive-early-data-29368cae
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?